Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2018 | 1 |
2019 | 1 |
2020 | 2 |
2021 | 1 |
2022 | 2 |
2024 | 0 |
Search Results
6 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
State-of-the-art knowledge on the regulation of advanced therapy medicinal products.
Per Med. 2022 May;19(3):251-261. doi: 10.2217/pme-2021-0111. Epub 2022 Mar 16.
Per Med. 2022.
PMID: 35293224
Review.
Mechanistic Modelling Identifies and Addresses the Risks of Empiric Concentration-Guided Sorafenib Dosing.
Ruanglertboon W, Sorich MJ, Hopkins AM, Rowland A.
Ruanglertboon W, et al.
Pharmaceuticals (Basel). 2021 Apr 21;14(5):389. doi: 10.3390/ph14050389.
Pharmaceuticals (Basel). 2021.
PMID: 33919091
Free PMC article.
Item in Clipboard
A clinical scoring tool validated with machine learning for predicting severe hand-foot syndrome from sorafenib in hepatocellular carcinoma.
Abuhelwa AY, Badaoui S, Yuen HY, McKinnon RA, Ruanglertboon W, Shankaran K, Tuteja A, Sorich MJ, Hopkins AM.
Abuhelwa AY, et al. Among authors: ruanglertboon w.
Cancer Chemother Pharmacol. 2022 Apr;89(4):479-485. doi: 10.1007/s00280-022-04411-9. Epub 2022 Feb 28.
Cancer Chemother Pharmacol. 2022.
PMID: 35226112
Free PMC article.
Clinical Trial.
Item in Clipboard
The effect of proton pump inhibitors on survival outcomes in advanced hepatocellular carcinoma treated with sorafenib.
Ruanglertboon W, Sorich MJ, Logan JM, Rowland A, Hopkins AM.
Ruanglertboon W, et al.
J Cancer Res Clin Oncol. 2020 Oct;146(10):2693-2697. doi: 10.1007/s00432-020-03261-3. Epub 2020 May 24.
J Cancer Res Clin Oncol. 2020.
PMID: 32449002
Item in Clipboard
Plasma extracellular nanovesicle (exosome)-derived biomarkers for drug metabolism pathways: a novel approach to characterize variability in drug exposure.
Rowland A, Ruanglertboon W, van Dyk M, Wijayakumara D, Wood LS, Meech R, Mackenzie PI, Rodrigues AD, Marshall JC, Sorich MJ.
Rowland A, et al. Among authors: ruanglertboon w.
Br J Clin Pharmacol. 2019 Jan;85(1):216-226. doi: 10.1111/bcp.13793. Epub 2018 Nov 16.
Br J Clin Pharmacol. 2019.
PMID: 30340248
Free PMC article.
Item in Clipboard
Effect of early adverse events resulting in sorafenib dose adjustments on survival outcomes of advanced hepatocellular carcinoma patients.
Ruanglertboon W, Sorich MJ, Rowland A, Hopkins AM.
Ruanglertboon W, et al.
Int J Clin Oncol. 2020 Sep;25(9):1672-1677. doi: 10.1007/s10147-020-01698-7. Epub 2020 May 16.
Int J Clin Oncol. 2020.
PMID: 32417993
Clinical Trial.
Item in Clipboard
Cite
Cite